Studies demonstrated its use as a downstream target of NOX2 to increase the incidence of arrhythmias in AngII-induced mouse models (102, 103), suggesting that NOX2 is involved in cardiac structural remodeling. The gene discussed is CYBB; the disease is cardiac arrhythmia.